VINCENT M LEVERETT

Allopathic & Osteopathic Physicians|Family Medicine GIG HARBOR, WA NPI 1326058744

General Payments — all program years on this page

$1,889.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $450.81 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $450.8122

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $336.6818
2019 $393.1822
2020 $146.637
2021 $11.641
2022 $16.501
2023 $533.5724
2024 $450.8122

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084883036 Hologic Sales and Service, LLC $15.01 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097294118 Novo Nordisk Inc $13.47 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097420878 Novo Nordisk Inc $16.79 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097540415 Novo Nordisk Inc $15.91 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097780785 Novo Nordisk Inc $23.08 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104323318 AstraZeneca Pharmaceuticals LP $22.48 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105855078 AstraZeneca Pharmaceuticals LP $23.02 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115867244 Amgen Inc. $26.68 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115867252 Amgen Inc. $21.33 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116493124 GlaxoSmithKline, LLC. $20.37 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116545660 GlaxoSmithKline, LLC. $20.04 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116646805 GlaxoSmithKline, LLC. $18.74 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117963660 Boehringer Ingelheim Pharmaceuticals, Inc. $20.12 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131023723 PFIZER INC. $22.86 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131681261 PFIZER INC. $20.57 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132033737 PFIZER INC. $17.28 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135466472 Lilly USA, LLC $25.87 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135491646 Lilly USA, LLC $13.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135509230 Lilly USA, LLC $26.72 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151088503 Phathom Pharmaceuticals, Inc. $19.39 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151088505 Phathom Pharmaceuticals, Inc. $30.67 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154046067 iRhythm Technologies, Inc. $16.68 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.